GRIFFIN Study Update #ASH19 @LevineCancer

GRIFFIN Study Update #ASH19 @LevineCancer

User Photo
ash

9 months
25 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Peter Voorhees, MD of @LevineCancer discusses the depth of response to dara, lenalidomide, bortezomib, and dexamethasone (RVd) improves over time in patients with transplant-eligible newly diagnosed multiple myeloma: GRIFFIN study update.

Up Next Autoplay